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ABSTRACT
Background. Chronic fatigue syndrome (CFS) and major depressive disorder (MDD) share many
symptoms and aetiological factors but may have different neurobiological underpinnings. We
wished to determine the profile of the biological variables disturbed in CFS and MDD, and identify
any critical factors that differentiate the disorders.
Methods. Thirty patients with CFS, 20 with MDD and 15 healthy controls – matched group-wise
for age and sex – were recruited. Subjects were given a detailed battery of motor and cognitive tests,
including measures of psychomotor speed, memory and maximal voluntary muscle contraction in
both the morning and evening that were balanced to avoid order effects.
Results. CFS patients generally performed worse on cognitive tests than healthy controls, but better
than patients with MDD. Both patient groups had markedly impaired motor function compared
with healthy controls. MDD subjects showed a significantly greater diurnal improvement in
maximal voluntary contraction than healthy controls.
Conclusions. Patients with CFS and MDD show similarly substantial motor impairment, but
cognitive deficits are generally more marked in MDD. Diurnal changes in some functions in MDD
may differentiate the disorder from CFS.
INTRODUCTION
The nature of chronic fatigue syndrome (CFS)
or ‘myalgic encephalomyelitis ’ (ME) remains
controversial. Some clinicians and most patients
stress that these conditions are primarily post-
infectious and that any emotional disturbance is
secondary (Behan & Bakheit, 1991). However,
50–70% of CFS sufferers satisfy criteria for
psychiatric disorders, particularly depression,
which cannot simply be attributed to the effects
of prolonged disability (David, 1991; Kendal,
1991). It follows that CFS may share essential
aetiological featureswithmooddisorder. Indeed,
it may best be thought of as a syndrome
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characterized by both fatigue and psychiatric
morbidity, triggered by physical and psycho-
social stressors, and maintained by biological
and psychological factors (Lawrie et al. 1997a).
Depressive disorder could be described similarly
(Kendal, 1991). It is, therefore, important to
measure the quantitative similarities and differ-
ences between the two disorders.
The present study extends the parallel under-
standing of CFS and major depressive disorder
(MDD) by a detailed investigation of neurobio-
logical indices. There are preliminary studies of
motor and cognitive function in CFS and MDD
(which form the basis for hypotheses we
examined here) but none is definitive and few
bring together more than a single domain of in-
vestigation. For example, patients with CFS
report an increased perception of muscular effort
despite submaximal performance on exercise
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testing (Stokes et al. 1988; Riley et al. 1990), but
the same may be true in depression, where
impairment of motor function extends even to
maximal voluntary hand grip (Cohen et al.
1982; Moffoot et al. 1994). Subjective reports of
cognitive impairment in CFS are supported by
objective evidence for slowed reaction time and
poor memory or attention (Millon et al. 1989;
Altay et al. 1990; Riccio et al. 1992; Grafman et
al. 1993; MacDonald et al. 1993; Ray et al.
1993; Sandman et al. 1993; Schmaling et al.
1994; Cope et al. 1995; DeLuca et al. 1995;
Joyce et al. 1996; Marcel et al. 1996; Marshall et
al. 1997; Vollmer-Conna et al. 1997; Wearden &
Appleby, 1997; Johnson et al. 1998). A com-
parison with depression suggests a similar
pattern of impairments (e.g. Austin et al. 1992).
However, both motor and cognitive impairments
tend to be maximal in the morning and improve
over the day in depression (Moffoot et al. 1994;
Porterfield et al. 1997). By contrast, CFS patients
generally report that symptoms worsen in the
evening, although there is little objective data on
this point.
We have examined a group of CFS patients
with measures of isometric strength, subjective
effort, mood and an appropriate series of
neuropsychological tests, in the morning and
evening, and compared them with groups of
both depressed and healthy controls. We also
measured endocrine function and cerebral per-
fusion, but provide accounts of these investi-
gations elsewhere (MacHale et al. 1998, 2000).
We specifically tested the hypothesis that the
cognitive and motor impairments in depression
and CFS would be expressed similarly as
reductions in performance as compared to
healthy controls, but with diurnal improvement
in depression and evening worsening in CFS.
METHOD
Approval for the project was obtained from the
appropriate Ethics Committee.
Subjects
Thirty patients satisfying operationalized criteria
for CFS (Fukuda et al. 1994) were recruited
from the local ME association self-help group
(Nfl 13) and from the regional infectious dis-
eases unit (Nfl 17). Where possible, patients
were selected to be over 30 years of age so that
clear evidence of the level of pre-morbid function
was obtainable. Sixteen subjects were medi-
cation-free at the time of assessment, with the
remaining 14 being prescribed either antidepres-
sants (10), hypnotics}anxiolytics (4) and}or
endocrine replacement (2 on thyroxine, 1 on the
oral contraceptive pill). Patients were excluded if
there had been any change in their medication in
the previous 3 weeks.
Twenty patients with major depression by
DSM-III-R criteria (APA, 1987), matched
group-wise for age and sex, were recruited from
the wards and out-patient services of the Royal
Edinburgh Hospital. They were recruited for
this study and a within subjects study of diurnal
variation in MDD (12 had diurnal variation
worst in the morning, eight were worst in the
evening) and have not been previously reported.
Five MDD patients were medication-free at the
time of assessment, with the remaining 15 being
prescribed antidepressants (14), hypnotics}
anxiolytics (3), thyroxine (2) and}or lithium (1)
in doses which had been stable for at least
3 weeks. A healthy control group of 15 subjects
was also recruited, matched for age and sex,
from hospital staff and friends of the CFS}ME
patients.
All subjects received a standardized psychi-
atric interview, the Schedule for Affective Dis-
orders and Schizophrenia (SADS) (Endicott &
Spitzer, 1978) to establish any psychiatric
diagnosis. Potential CFS}ME subjects with
current co-morbid psychiatric disorders, such
as depression, were excluded, but those with a
previous history of co-morbid depression were
not (Fukuda et al. 1994). All subjects also
underwent a comprehensive physical examin-
ation, and blood screening as thought necessary,
to exclude any physical illness that could be
responsible for the fatigue or depression. All
pre-menopausal female subjects were required
to have a negative pregnancy test before in-
clusion. The severity of depression symptoms
were rated using the 17-item Hamilton De-
pression Rating Scale (HDRS) (Hamilton,
1960). Pre-morbid IQ was assessed with the
revised National Adult Reading Test (NART)
(Nelson & Willison, 1991).
The Befindlichskeitskala scale (BFS) (Von
Zerssen et al. 1974) was used to measure levels of
depression and fatigue in both the morning and
evening. This is a self-rating mood scale, with
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Table 1. Clinical characteristics of CFS, MDD and healthy control subjects (CON ) (mean (S.D.))
CFS MDD CON
Sex (male}female) 11}19 8}12 4}11
Age (years) 44–2 (10–3) 44–0 (12–1) 41–1 (12–8)
NART IQ 114–2 (10–3) 119–4 (9–6) 113–0 (9–5)
Handedness score 17–6 (13–3) 14–6 (14–3) 18–7 (10–3)
Duration of current episode (weeks) 270–1 (189–2) 44–3 (61–8) —
Illness onset age (years) 38–1 (10–0) 29–7 (14–2) —
Hamilton score 8–8 (2–3) 25–6 (5–8) 0–6 (0–8)
Fatigue severity
Likert scoring 27–1 (3–6) — —
GHQ type scoring 10–4 (0–9) — —
SF 36
Health transition 2–9 (1–1) — —
Bodily pain 41–9 (24–4) — —
General health 31–3 (18–4) — —
Mental health 68–3 (16–8) — —
Vitality 23–2 (17–9) — —
Physical functioning 38–5 (20–2) — —
Physical role limitations 1–7 (9–1) — —
Emotional role limitations 80–0 (34–6) — —
Social functioning 36–2 (24–4) — —
impressive validity and reliability, in which
subjects choose from 28 positive}negative word
pairs to describe their state of mind (scoring 2 or
0 respectively, or 1 if undecided, giving a total
score range of 0–56 and a range of 0–16 for the
depression and fatigue items).
In CFS subjects, the severity of fatigue was
scored on the Chalder scale (Chalder et al. 1993)
while functional impairment was measured with
the SF36 (Ware & Sherbourne, 1992). The SF36
is a validated self-report questionnaire, scaled
scores giving levels of current functioning that
vary from 0 to 100% of normal (other than
health transition where scores range from 0–5
with lower numbers reflecting greater improve-
ment over the past year). Demographic data and
clinical scores are summarized in Tables 1 and 2.
Cognitive and motor function assessment
A comprehensive battery of neuropsychological
tests was administered. The CFS and healthy
control groups completed the Block Design
subtest of the Wechsler Adult Intelligence Scale-
Revised (WAIS-R) (Wechsler, 1981), Verbal
Fluency (Benton & Hamsher, 1978), Trails A
andB (Reitan, 1958), PairedAssociates Learning
(PAL) (Wechsler, 1981), the Boston Naming
Test (Kaplan et al. 1983), the 2- and 4-second
versions of the Paced Auditory Serial Addition
Test (PASAT) (Brittain et al. 1981), and the
California Verbal Learning Test (CVLT) (Delis
et al. 1987).
The CFS and healthy control groups com-
pleted a number of tests in both the morning and
evening on matched, parallel versions of : digit
span forwards and backwards (Randt & Brown,
1983) ; reaction time measures from the Cam-
bridgeNeuropsychological Test AutomatedBat-
tery (CANTAB) (Sahakian & Owen, 1992) ; and
a sustained hand grip test, which required
subjects tomaintain a hand grip at 10 kg pressure
on a dynamometer, for as long as possible, up to
a maximum of 3 min. Immediately after the
latter, subjects were asked to complete the Borg
effort scale (Borg, 1982).
The remaining cognitive and motor tasks
were completed by all subjects in both the
morning and evening. The Digit Symbol Sub-
stitution Test (DSST) (Wechsler, 1981) was
followed by the Auditory Verbal Learning Test,
including the delayed recall and recognition
sections (AVLT) (Rey, 1964; Lezak, 1983;
Crawford et al. 1989). The AVLT is a test of
immediate, short- and long-term memory. A 15-
item list (A) is read aloud to participants who
are asked to recall the items immediately and
after four consecutive repetitions. A second
word list (B) is then presented, which subjects
are asked to repeat, before recalling list A again.
This first part of the AVLT is usually completed
in 15 min. Delayed recall and recognition of list
A are then tested after 30 min. Finally, subjects
were asked to squeeze a handgrip dynamometer
as hard as possible on three occasions in both
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Table 2. BFS symptom ratings (mean (S.D.)) morning and evening in CFS, MDD and healthy
control subjects (CON)
BFS CFS MDD CON
F value
Group effect
Time effect
Interaction
P value
Group effect
Time effect
Interaction
Fatigue a.m. 9–6 (5–3) 10–2 (5–9) 2–5 (4–6) 15–7 ! 0–001*
p.m. 9–7 (4–8) 9–2 (5–1) 3–5 (5–1) 0–01 1–0
0–4 0–7
Depression a.m. 3–6 (3–0) 9–0 (5–0) 1–0 (1–6) 24–4 ! 0–001
p.m. 3–9 (3–4) 8–1 (5–0) 1–7 (2–8) 0–01 0–9
0–9 0–4
Total scores a.m. 21–8 (12–4) 38–1 (14–3) 6–3 (6–6) 48–6 ! 0–001
p.m. 22–9 (11–6) 38–8 (12–2) 8–1 (8–8) 0–4 0–5
0–03 1–0
* CFS, MDD"CON (P! 0–05) both morning and evening.
 MDD"CFS, CON (P! 0–05) both morning and evening.
 MDD"CFS"CON (P! 0–05) both morning and evening.
hands (averaged to assess maximum voluntary
contraction in each hand).
All the diurnal tests were conducted twice in a
balanced design, to avoid order effects. Subjects
were randomly allocated to being tested first at
8 a.m. and then 8 p.m. of the same day or 8 p.m.
followed by 8 a.m. the next morning. Parallel
versions of all the repeated tests were used in the
second testing session. The order of particular
tests was however the same in both sessions.
Statistical analysis
Cognitive and motor tests given to only CFS
and control subjects were compared by one-way
analysis of variance (ANOVA). The clinical
ratings (BFS), cognitive and motor tests com-
pleted by subjects in both morning and evening
were compared by repeated measures ANOVA
with an interaction term for the hypothesized
group by time effects. Significant group, time or
interaction effects were then examined with
planned ANOVA and post hoc Scheffe! tests to
identify the nature of the effects, controlling for
multiple comparisons. The analyses were re-
peated comparing CFS subjects on and off
medication.
RESULTS
Subjects
As shown in Table 1, the subject groups were
well matched for age and pre-morbid IQ, but
male healthy controls were under-represented.
The CFS subjects had become ill at an older age
than the MDD subjects, but their current (and
only) episode had been longer. As expected, the
levels of depressive symptomatology were higher
in MDD subjects than CFS subjects, who in
turn had higher levels than the healthy controls.
The CFS subjects reported high levels of
fatigue and were substantially incapacitated
as measured by several ratings on the
SF36 – particularly in levels of vitality, physical
and social functioning and general health. The
mean score of 2–9 on health transition indicates
that most CFS subjects had not noted much
change in their condition over the previous year.
CFS and MDD subjects scored equally high
on the BFS fatigue score, but levels of depression
were much higher in MDD than CFS patients
(see Table 2). Both CFS and healthy subjects
tended to report greater levels of symptoms in
the evening than in the morning, with the
opposite being true in the MDD subjects, but
none of the diurnal changes in symptoms was
statistically significant.
Cognition
Table 3 shows the results from the neuro-
psychological tests that were given to CFS and
healthy controls on only one occasion. The
differences were small. The only statistically
significant effect is the fewer total number of
words produced on the verbal fluency test.
However, the CFS subjects consistently do
slightly worse than the healthy controls. (They
also show a tendency to do relatively worse, as
measured by effect sizes, on ‘harder’ than
‘easier ’ tests – i.e. scoring lower on Trails B than
A, lower on PAL hard than easy pairs, and
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Table 3. Neuropsychological test results (mean (S.D.)) in CFS and healthy control subjects
(CON )
CFS CON
Test statistic
F P value (Effect size)*
Trails A 25–7 (11–6) 25–3 (7–0) 0–02 0–9 (0–03)
Trails B 59–2 (19–9) 56–3 (14–8) 0–2 0–6 (0–19)
Block design 12–3 (3–3) 12–4 (3–1) 0–01 0–9 (0–03)
Boston naming test 56–8 (4–2) 55–9 (2–9) 0–06 0–5 (0–31)
Verbal fluency (all FAS) 44–1 (11–5) 51–7 (12–3) 4–1 0–048 (0–61)
PASAT
2 s 36–4 (10–1) 42–7 (10–4) 3–7 0–06 (0–61)
4 s 52–7 (6–1) 55–3 (5–6) 1–9 0–2 (0–46)
Paired associates
Easy 11–2 (1–2) 11–6 (0–7) 1–6 0–2 (0–57)
Hard 7–5 (3–6) 9–4 (2–5) 3–2 0–08 (0–76)
CVLT
Semantic cluster ratio 0–0 (1–2) 0–2 (1–5) 0–2 0–6 (0–13)
(standard score)
Serial cluster ratio
(standard score)
fi0–2 (1–0) fi0–5 (0–9) 0–6 0–4 (0–33)
Recognition hits
(standard score)
fi0–4 (1–5) 0–1 (1–1) 1–3 0–3 (0–45)
Discriminability
(standard score)
0–0 (0–9) 0–4 (0–6) 2–5 0–1 (0–67)
Long v. short
delay free recall
(difference score)
fi0–2 (0–6) fi0–4 (1–5) 0–7 0–4 (0–13)
* Effects sizes (in s.d. units) are calculated as the difference in means divided by the standard deviation in controls.
Table 4. Neuropsychological performance, sustained hand grip time and Borg ratings – morning
and evening (mean S.D.) – in CFS and healthy control subjects (CON)
CFS CON
F value
Group effect
Time effect
Interaction
P value
Group effect
Time effect
Interaction
CANTAB
Reaction time–reaction latency a.m. 543–0 (124–5) 491–5 (61–9) 3–8 0–06
p.m. 530–1 (104–5) 475–9 (64–6) 0–7 0–4
0–01 0–9
Reaction time–move latency a.m. 427–2 (110–7) 331–6 (70–2) 10–3 0–003*
a.m. 416–1 (99–0) 333–1 (59–4) 0–2 0–6
0–4 0–5
Reaction time–total latency a.m. 697–6 (156–8) 609–5 (78–0) 5–8 0–02*
p.m. 680–4 (134–7) 596–5 (82–5) 0–6 0–4
0–01 0–9
Digit Span
Forwards a.m. 6–9 (1–6) 7–4 (1–3) 0–5 0–5
p.m. 7–1 (1–3) 7–2 (1–5) 0–01 0–9
1–1 0–3
Backwards a.m. 5–8 (1–1) 5–2 (1–3) 0–4 0–5
p.m. 5–5 (1–3) 5–7 (1–5) 0–6 0–5
5–1 0–03
Sustained hand grip time (s) a.m. 122–6 (69–2) 158–0 (38–6) 6–2 0–02
p.m. 113–6 (63–0) 166–0 (37–4) 0–01 0–9
2–2 0–1
Borg rating scale a.m. 7–1 (2–3) 5–9 (2–5) 5–0 0–03
p.m. 7–5 (2–5) 5–5 (2–3) 0–03 0–9
2–4 0–1
* CFS worse than CON (P! 0–05) both morning and evening.
 CFS worse than CON (P! 0–05) in evening only.
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Table 5. Neuropsychological test results – morning and evening (mean (S.D.)) – in CFS, MDD
and healthy control subjects (CON )
CFS MDD CON
F value
Group effect
Time effect
Interaction
P value
Group effect
Time effect
Interaction
Digit symbol a.m. 10–5 (2–8) 7–4 (2–8) 12–4 (2–0) 12–3 ! 0–001*
substitution p.m. 10–7 (2–9) 9–2 (3–2) 12–6 (1–8) 6–6 0–013
(age scaled) 3–7 0–04
AVLT
Immediate recall a.m. 49–6 (10–3) 38–2 (10–8) 55–4 (9–4) 7–7 0–001*
p.m. 51–3 (10–5) 48–5 (12–7) 56–5 (8–3) 5–0 0–05
1–4 0–4
Distraction a.m. 9–2 (3–3) 7–0 (3–8) 12–2 (2–4) 14–2 ! 0–001
p.m. 10–1 (3–3) 7–3 (3–9) 12–6 (2–7) 1–4 0–2
0–2 0–8
Delayed recall a.m. 8–8 (3–8) 5–9 (4–7) 12–3 (2–7) 12–8 ! 0–001
p.m. 9–7 (3–6) 7–3 (4–1) 11–9 (2–7) 1–3 0–3
0–8 0–5
Recognition a.m. 11–0 (3–4) 8–3 (4–4) 13–7 (1–7) 14–2 ! 0–001
p.m. 11–8 (3–6) 9–2 (3–6) 13–5 (1–8) 0–8 0–4
0–4 0–6
* MDD!CFS, CON (P! 0–05) in morning, MDD!CON (P! 0–05) in evening.
 MDD, CFS!CON (P! 0–05) in morning, MDD!CFS, CON (P! 0–05) in evening.
 MDD!CFS!CON (P! 0–05) in morning, MDD!CON (P! 0–05) in evening.
 MDD!CFS, CON (P! 0–05) in morning and evening.
 Group by time interaction significant but no statistically significant post hoc differences in diurnal change between groups.
Table 6. Mean of three maximum voluntary contractions in right and left hands (mean (S.D.))
morning and evening in CFS, MDD and healthy control subjects (CON )
Maximum
voluntary
contraction CFS MDD CON
F value
Group effect
Time effect
Interaction
P value
Group effect
Time effect
Interaction
Right hand a.m. 24–3 (12–4) 20–6 (11–5) 35–8 (9–2) 5–9 0–005*
p.m. 25–7 (13–6) 25–2 (10–8) 35–2 (8–4) 9–4 0–003
5–8 0–005
Left hand a.m. 22–4 (11–5) 18–9 (11–9) 34–7 (8–8) 8–0 0–001
p.m. 23–6 (11–6) 20–0 (11–8) 33–9 (7–7) 3–2 0–08
2–6 0–08
* CFS, MDD!CON (P! 0–05) in morning and CFS!CON (P! 0–05) in evening.
 CFS, MDD!CON (P! 0–05) in morning and evening.
 Greater increase (P! 0–05) morning to evening in MDD than CON.
lower on PASAT 2 as compared to 4 s – but
these differences were not statistically significant
on testing with paired t tests). This generally
poorer performance is also evident in the results
from those tests that were given to CFS and
healthy control groups in both the morning and
evening (see Table 4). CFS subjects had statis-
tically significantly slower reaction times, at-
tributable to movement rather than reaction
latency, at both testing times. The results of the
digit span backwards test show the predicted
differential diurnal pattern of worsening in
CFS with improvement in healthy control
groups – although the scores themselves do not
generally show a statistically significantly deficit
in CFS and none of the other tests in this section
show diurnal worsening in CFS.
Table 5 shows the results of the tests specifi-
cally employed to test our diurnal variation
hypothesis – which was not confirmed. Most
test results improved, although not to a statis-
tically significant extent, from morning to
evening in all three groups. Patients with MDD
tended to do worst on all tests at both time
points. The only statistically significant group
by time interaction is on the digit symbol
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substitution test, but post hoc testing did not
reveal any statistically significant between group
diurnal changes.
Motor tests
The results from the sustained hand grip tests
are shown in Table 4. CFS patients were able to
sustain a 10 kg contraction for less time than the
controls in both the morning and evening, and
reported greater subjective effort, but these
differences were only statistically significant in
the evening and the group by time interactions
were non-significant.
The mean of three maximal contractions in
the right and left hands of all three subject
groups are shown in Table 6. The CFS patients’
mean scores are very similar to those of the
MDD patients, being approximately 25–30%
lower than in healthy controls in both hands at
both time points in both groups. Motor per-
formance tended to improve from morning to
evening in CFS, as in MDD, but worsen in
healthy controls ; although the group by time
interaction effect is only significant for a greater
improvement in MDD than the healthy control
group (P!0–05) for the right (dominant) hand.
Controlling for medication status in CFS
All the above neurobiological variables (Nfl 42)
were compared between CFS subjects on
(Nfl 16) and off (Nfl 14) medication. Although
two statistically significant differences (P! 0–05)
could have occurred by chance alone, no such
differences were found. Concomitant medication
is therefore unlikely to explain the between
group differences described above.
DISCUSSION
Main findings
We report the results from a detailed study of
motor and cognitive function in CFS as com-
pared with both depressed and healthy control
groups. Patients with CFS and MDD reported
similar levels of fatigue and showed similarly
large decrements on maximal voluntary contrac-
tions. The MDD group had a significantly
greater burden of depressive symptoms and
more obviously impaired cognitive performance.
Patients with CFS do have neuropsychological
deficits, but these are subtle and most apparent
when information processing demands are high-
est or after fatiguing exercise (Blackwood et al.
1998). We found only limited evidence of
differential diurnal effects on cognitive and
motor function in CFS and MDD.
Limitations
We recruited some of the CFS subjects from a
local self-help group, which may have introduced
bias, for example to severity and chronicity.
However, there is an approximate 50% overlap
in the local membership and hospital out-patient
attenders and any bias would probably have
reduced differences between CFS and MDD
subjects. Our recruitment strategy means that
our results apply to those with CFS as well as to
those patients who regard themselves as suffering
from ‘ME’. It would have been informative to
have a group of CFS subjects with depression,
but practical considerations dictated our ap-
proach. Including medicated CFS subjects, who
were usually taking antidepressants for previous
depression or current symptomatic relief (of a
possible subclinical depression), means that our
results are potentially confounded by medication
effects (although we did not find any), but also
makes them applicable to the majority of CFS
patients with co-morbid psychiatric symptoms.
Most of our depressed subjects were medicated,
as they had presented for treatment, and it is
possible that sedative or anticholinergic effects
worsened test performance – although the bene-
fits of treating depression probably outweigh
any adverse effects in MDD patients (Calev et
al. 1986).
We are limited in the comparisons that can be
made of cognitive function across the three
subject groups as the MDD patients only
completed some of the tests. However, the
results of the AVLT and DSST demonstrated
pronounced psychomotor and memory deficits
in MDD, which were greater than those in CFS.
Although we found some of the predicted
differential effects of diurnal variation in CFS
and MDD as compared to controls, the effects
were unimpressive and the MDD subjects were
specifically recruited to have diurnal variation in
their symptoms, whereas the CFS subjects were
not.
Cognitive function
We report several statistically significant differ-
ences in neuropsychological performance be-
tween CFS and healthy control subjects, on:
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verbal fluency, CANTAB reaction time, psycho-
motor speed (DSST) and AVLT measures of
immediate recall and recognition. These findings
are very much in keeping with previous reports,
which have also revealed objective evidence for
impairments in verbal fluency (Krupp et al.
1994) and other executive tasks (Grafman et al.
1993; Ray et al. 1993; Wood et al. 1994) ;
reaction time (Smith et al. 1996; Marshall et al.
1997; Vollmer-Conna et al. 1997) ; psychomotor
speed (Smith et al. 1996; Michiels et al. 1997) ;
and in various measures of attention and
memory (Grafman et al. 1993; McDonald et al.
1993; Sandman et al. 1993; Krupp et al. 1994;
Schmaling et al. 1994; Cope et al. 1995; DeLuca
et al. 1995; Marcel et al. 1996; Smith et al. 1996;
Marshall et al. 1997; Wearden & Appleby, 1997;
Johnson et al. 1998; Michiels et al. 1998). The
effects are modest and show little differential
impairment on different test categories. A
parsimonious explanation is that of a generalized
impairment in information processing, perhaps
attributable to low arousal or, given that the
slower reaction times in our CFS subjects were
attributable to movement rather than reaction
latency, a difficulty in the execution of activity.
We found some statistically significantly
greater impairments in MDD compared with
CFS subjects, on measures of psychomotor
speed (DSST) and memory. These results differ
from those of the few previous comparisons,
which have failed to find such differences
(Schmaling et al. 1994; Cope et al. 1995; DeLuca
et al. 1995; Marshall et al. 1997; Vollmer-Conna
et al. 1997). We suspect that different outcomes
depend upon the exclusion of CFS patients with
a current depressive illness and the inclusion of
more severe MDD cases. The similar degree of
fatigue and motor impairment in our CFS and
MDD patients suggests that the cognitive
differences are not simply attributable to non-
specific effects of illness severity.
Motor function
The shorter length of time that CFS subjects
sustained a hand grip in the right (dominant)
hand than healthy controls has not been pre-
viously reported, as far as we are aware.
Although we cannot definitely state that these
differences are not attributable to loss of muscle
power (e.g. due to disuse), isometric muscle
strength is generally normal in CFS (Lloyd et al.
1991; Kent-Braun et al. 1993; Blackwood et al.
1998) and it is parsimonious to link these results
to the complementary findings of increased effort
perception in these previous studies. The mean
of three maximal voluntary contractions was
strikingly lower in CFS subjects than in the
healthy controls, being similar to those with
MDD. Thus, patients with CFS have motor
problems that are as severe as those found in
MDD but a lesser degree of cognitive im-
pairment.
Diurnal variation
There is only partial support for our differential
diurnal variation hypothesis – i.e. improvement
in MDD and worsening in CFS as the day wears
on. The MDD patients ’ performances on cog-
nitive and motor tasks do tend to objectively
improve, as other have previously shown (Mof-
foot et al. 1994; Porterfield et al. 1997), but these
improvements are not statistically different from
those in CFS patients. There is certainly no
consistent diurnal worsening in function in CFS
as compared to MDD. Nonetheless, the fact
that symptoms and task performance in CFS do
not generally fluctuate diurnally, whereas they
clearly can in MDD, suggests that there are
neurobiological differences between the dis-
orders despite many similarities in aetiological
factors and symptoms. This is unlikely to be
simply a matter of severity as our subjects with
CFS performed as poorly as our MD subjects
on many measures.
Implications
We have recently advanced an hypothesis that
CFS may be primarily attributable to a failure in
effort mobilization that is most evident on
‘effortful ’ or controlled motor or cognitive
activity (Lawrie et al. 1997b). Others have had
similar ideas (Joyce et al. 1996). On self-rating of
fatigue, and on objective measures of motor
performance, patients with CFS and severe
depressive illness were similar. Given the power-
ful evidence that retardation of motor function
is a key feature of severe depressive illness
(Parker & Hadzi-Pavlovic, 1996), this emphasis
on motor performance is something that the
conditions share. Why they do and what the
underlying mechanisms are remain uncertain.
In regard to cognitive function, however, the
two groups of patients studied in this report
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show clear differences that suggested a more
profound impairment of function in patients
with severe depression. CFS subjects did tend to
perform relatively more poorly than healthy
controls on ‘harder’ tasks with greater demands
on information processing capacity. Effortful
cognition is also compromised in MDD (Cohen
et al. 1982; Austin et al. 1992; Lawrie et al.
1997b), but the impairments at rest are much
greater. CFS and MDD patients differ im-
portantly in the impact of an exercise stressor
upon neuropsychological performance (Black-
wood et al. 1998).
Our observations accord with early reports of
objectively mild but subjectively severe cognitive
deficits in CFS (Millon et al. 1989; Altay et al.
1990; Ray et al. 1993). These were often
interpreted as evidence of exaggerated com-
plaints in CFS, as were early reports of increased
effort perception, and usually attributed to
personality difficulties (Buckley et al. 1999). To
us, it is just as likely that subjective reports
reflect processing requirements and objectively
impaired neuropsychological function in CFS.
In this report, there are important similarities
and differences between CFS and MDD, as we
have found in studies of neuroendocrine function
(MacHale et al. 1998) and with Single Photon
Emission Tomography (MacHale et al. 2000).
CFS and MDD may have similar provoking
factors and an important overlap in the motor
domain. If motor disturbance is primary, as
CFS patients typically regard it, we still do not
understand why that has different consequences
for cognition in CFS from that in severe
depression. Alternatively, psychomotor retar-
dation in MDD may be associated with a less
reversible impairment of cognitive function than
that in CFS. Fatigue needs to be studied in a
range of depressed patients before we can be
confident that the crossover of impairment from
the motor to the cognitive domain is as specific
to CFS as it currently appears to be.
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Cathy Murray for technical assistance, local phy-
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